A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
Regulations Take the Lead in Healthcare Restroom Design
AHN Allegheny Valley Hospital Opens Expanded Inpatient Rehabilitation Unit
HSHS and Lifepoint Rehabilitation Partner on New Inpatient Rehab Hospital in Green Bay
Turning Facility Data Into ROI: Where Healthcare Leaders Should Start
Sutter Health Breaks Ground on Advanced Cancer Center and Care Complex